Through Invitae’s PGx medication optimization tools, clinicians can address barriers to precision medication management and achieve optimal prescribing. Actionable, personalized drug and dose optimization recommendations are based on a combination of genetics and the latest evidence, so healthcare providers can easily design an effective regimen for each individual patient.
*Invitae accepts reimbursement at 100% of the CMS 2020 National Limitation Amount (NLA) for Invitae SARS-CoV-2 Test, (LOINC: 94500-6), which is currently $100.00. Invitae can bill payers for the cost of the test, so consumers do not incur upfront test costs; however, physician fees are separate and charged to the consumers directly by the healthcare provider. If consumers choose not to take advantage of payer options they can pay the self-pay price of $75.00.